SZEY-2108

· Suzhou Erye Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SZEY-2108, covering 2024-12-03 to 2024-12-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of the Safety, Tolerability, and PK of SZEY-2108 Administered Intravenously to HVs in SAD and MAD Cohorts [Phase 1]

See pricing